Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

ARIA-MASK study group

Research output: Contribution to journalArticlepeer-review

Abstract

The current COVID-19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on immunological effects on the diseased patient.

Original languageEnglish
JournalAllergy
Early online date24 Apr 2020
DOIs
Publication statusE-pub ahead of print - 24 Apr 2020

Fingerprint

Dive into the research topics of 'Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement'. Together they form a unique fingerprint.

Cite this